All n = 315 | Male n = 155 | Female n = 160 | p-value | |
---|---|---|---|---|
Age | 78 ± 3.44 | 78 ± 3.18 | 78.5 ± 3.68 | 0.32 |
BMI | 26.51 ± 3.90 | 26.16 ± 3.01 | 26.87 ± 4.59 | 0.14 |
Weight | 74.01 ± 12.63 | 78.99 ± 9.20 | 69.18 ± 13.13 | < 0.001 |
Height | 166.95 ± 9.28 | 174.77 ± 6.91 | 160,35 ± 5.90 | < 0.001 |
CRP (mg/l)a | 5.1 (11.13) | 5.25 (12) | 45 (18.9) | 0.82 |
Glucose (mmol/l) | 5.81 ± 2.29 | 5.86 ± 2.10 | 5.75 ± 2.46 | 0.68 |
HDL (mmol/l) | 1.30 ± 0.33 | 1.19 ± 0.26 | 1.4 ± 0.36 | < 0.001 |
LDL (mmol/l) | 3.18 ± 1.0 | 3.07 ± 0.89 | 3.29 ± 1.08 | 0.048 |
Creatinine (μmol/l) | 79.51 ± 24.75 | 88.07 ± 24.88 | 71.23 ± 21.67 | < 0.001 |
GFR (ml/min/1.73m2) | 72.0 ± 22.1 | 74.5 ± 19.5 | 69.7 ± 24.2 | 0.057 |
History n (%) | ||||
Smoking * | 27 (8.6) | 22 (14.2) | 5 (3.1) | 0.005 |
Diabetes*b | 57 (18.1) | 28 (18.1) | 29 (18.1) | 0.46 |
Hyperlipidemia * | 73 (23.2) | 32 (20.6) | 41 (25.6) | 0.51 |
Angina pectoris * | 56 (17.8) | 28 (18.1) | 28 (18.1) | 0.44 |
Myocardial infarction*3 | 27 (8.6) | 19 (12.3) | 8 (5.0) | 0.021 |
Family history of CV *4 | 65 (20.6) | 24 (15.5) | 41 (25.6) | 0.026 |
Medications, n (%) | ||||
Statin treatment * | 69 (21.9) | 32 (20.6) | 37 (23.1) | 0.40 |
Beta receptor blockers* | 114 (34.9) | 54 (34.8) | 60 (37.5) | 0.63 |
ACE inhibitors* | 62 (17.5) | 27 (17.4) | 35 (21.9) | 0.15 |
Calcium channel blockers* | 51 (16.2) | 27 (17.4) | 24 (15) | 0.65 |
Diuretics* | 115 (36.5) | 48 (31) | 67 (41.9) | 0.045 |